Yuki Noguchi
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from vaccination and racial inequities in access to health, to cancer care, obesity and mental health.
Since joining NPR in 2008, Noguchi has also covered a range of business and economic news, with a special focus on the workplace — anything that affects how and why we work. In recent years, she has covered the rise of the contract workforce, the #MeToo movement, the Great Recession and the subprime housing crisis. In 2011, she covered the earthquake and tsunami in her parents' native Japan. Her coverage of the impact of opioids on workers and their families won a 2019 Gracie Award and received First Place and Best In Show in the radio category from the National Headliner Awards. She also loves featuring offbeat topics, and has eaten insects in service of journalism.
Noguchi started her career as a reporter, then an editor, for The Washington Post.
Noguchi grew up in St. Louis, inflicts her cooking on her two boys and has a degree in history from Yale.
-
Ivermectin's reputation keeps growing as a kind of cure-all, even for cancer — despite evidence it doesn't work.
-
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method.
-
GLP-1 weight loss drugs have transformed obesity treatment, but not everyone loses lots of weight. Researchers say figuring out why is the key to the future of this treatment method.
-
Fourteen companies in total have now reached what the administration calls most-favored-nation pricing deals. -
Immigrants make up a significant proportion of all the country's doctors. New policies are making it harder and less appealing for foreign-born physicians to come to the U.S. -
Immigrants make up about a quarter of all the country's doctors. New policies are making it harder and less appealing for foreign-born physicians to come to the U.S.
-
Telehealth for Medicare started during the pandemic and became popular quickly. But the shutdown put an abrupt halt to payments for the service. -
Medicare patients have embraced telehealth -- it's convenient and efficient. But many can't get it during the government shutdown.
-
Like many Americans, Scott Adams had insurance problems. But unlike most people he has powerful friends on social media, and when he asked President Trump for help, he got the cancer drug he needed. -
The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity rate is at 37%, down from 39.9%.
